HIV InSite
Home | Patient/Public | Audio | News | Links
transparent gif
transparent giftransparent gif

Comprehensive, up-to-date information on HIV/AIDS treatment, prevention, and policy from the University of California San Francisco

transparent giftransparent gif
transparent giftransparent gif

Editors' Picks

  • NEW: HIV Meds Quarterly
    Brief updates and analysis of new findings related to common therapies used by HIV clinicians. Spring 2008.
    • Research Briefs: Atazanavir Efficacy Data and Changes in Dosage Recommendations; Raltegravir Substitution for Enfuvirtide; HLA-B*5701 Screening
    • Reference Table: Etravirine-ARV Interactions
    • Fast Takes: Recent news about darunavir, lamivudine, lopinavir/ritonavir, amprenavir
  • HPV Infection in HIV-Seropositive Men and Women
    HPV and HIV, including both cervical and anal disease, and vaccine development. Grand Rounds, San Francisco General Hospital, 01/08.
  • 25 years of HIV
    Reflecting on scientific advances since isolating HIV in 1983, Anthony S. Fauci urges a renewed commitment to vaccine development. Nature, 05/14/08.

NewsWatch

transparent gif
transparent gif
SponsorsOther Sponsors
grey line
boehringer ingelheimBMS VirologygileadSun
grey line
About|Site Map|Feedback|Subscribe|Sponsors|Donate|Disclaimer
transparent gif
UCSF - Center for HIV Information

HIV InSite is a project of the UCSF Center for HIV Information. Copyright 2008, Regents of the University of California.